DNA vaccine using hemagglutinating virus of Japan-liposome encapsulating combination encoding mycobacterial heat shock protein 65 and interleukin-12 confers protection against Mycobacterium tuberculosis by T cell activation.

[1]  Y. Kaneda,et al.  Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey model. , 2005, Vaccine.

[2]  Y. Kaneda,et al.  Hemagglutinating virus of Japan protein is efficient for induction of CD4+ T-cell response by a hepatitis B core particle-based HIV vaccine. , 2004, Clinical immunology.

[3]  A. Moore,et al.  Progress in DNA‐based heterologous prime‐boost immunization strategies for malaria , 2004, Immunological reviews.

[4]  N. Ohara,et al.  Induction of Protective Cellular Immunity against Mycobacterium tuberculosis by Recombinant Attenuated Self-Destructing Listeria monocytogenes Strains Harboring Eukaryotic Expression Plasmids for Antigen 85 Complex and MPB/MPT51 , 2004, Infection and Immunity.

[5]  K. Lima,et al.  Efficacy of DNA-hsp65 vaccination for tuberculosis varies with method of DNA introduction in vivo. , 2003, Vaccine.

[6]  E. Pamer,et al.  CD8 T cell responses to infectious pathogens. , 2003, Annual review of immunology.

[7]  J. Flynn,et al.  Immunology of tuberculosis. , 2003, Annual review of immunology.

[8]  S. Yoshida,et al.  Baculovirus virions displaying Plasmodium berghei circumsporozoite protein protect mice against malaria sporozoite infection. , 2003, Virology.

[9]  Sang-Nae Cho,et al.  Comparative analysis of effects of cytokine gene adjuvants on DNA vaccination against Mycobacterium tuberculosis heat shock protein 65. , 2003, Vaccine.

[10]  S. Porcelli,et al.  Immunization with a mycobacterial lipid vaccine improves pulmonary pathology in the guinea pig model of tuberculosis. , 2003, International immunology.

[11]  H. Vordermeier,et al.  Improved immunogenicity of DNA vaccination with mycobacterial HSP65 against bovine tuberculosis by protein boosting. , 2003, Veterinary microbiology.

[12]  W. Britton,et al.  The combination of plasmid interleukin‐12 with a single DNA vaccine is more effective than Mycobacterium bovis (bacille Calmette–Guèrin) in protecting against systemic Mycobacterim avium infection , 2003, Immunology.

[13]  I. Orme,et al.  Pulmonary Necrosis Resulting from DNA Vaccination against Tuberculosis , 2003, Infection and Immunity.

[14]  C. L. Silva,et al.  Single dose of a vaccine based on DNA encoding mycobacterial hsp65 protein plus TDM-loaded PLGA microspheres protects mice against a virulent strain of Mycobacterium tuberculosis , 2003, Gene Therapy.

[15]  I. Srivastava,et al.  Gene Vaccines , 2003, Annals of Internal Medicine.

[16]  H. Kiyono,et al.  HIV Mucosal Vaccine: Nasal Immunization with gp160-Encapsulated Hemagglutinating Virus of Japan-Liposome Induces Antigen-Specific CTLs and Neutralizing Antibody Responses1 , 2003, The Journal of Immunology.

[17]  P. Andersen,et al.  Tuberculosis vaccine development. , 2002, Current opinion in pulmonary medicine.

[18]  R. G. Hewinson,et al.  Vaccination of Guinea Pigs with DNA Encoding the Mycobacterial Antigen MPB83 Influences Pulmonary Pathology but Not Hematogenous Spread following Aerogenic Infection with Mycobacterium bovis , 2002, Infection and Immunity.

[19]  W. Britton,et al.  Coexpression of Interleukin-12 Chains by a Self-Splicing Vector Increases the Protective Cellular Immune Response of DNA and Mycobacterium bovis BCG Vaccines against Mycobacterium tuberculosis , 2002, Infection and Immunity.

[20]  H. McShane,et al.  Protective Immunity against Mycobacterium tuberculosis Induced by Dendritic Cells Pulsed with both CD8+- and CD4+-T-Cell Epitopes from Antigen 85A , 2002, Infection and Immunity.

[21]  T. Yamano,et al.  Induction of a systemic immune response by a polyvalent melanoma-associated antigen DNA vaccine for prevention and treatment of malignant melanoma. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[22]  T. Udagawa,et al.  Pulmonary granulomas of guinea pigs induced by inhalation exposure of heat-treated BCG Pasteur, purified trehalose dimycolate and methyl ketomycolate. , 2002, Journal of medical microbiology.

[23]  I. Orme.  The search for new vaccines against tuberculosis , 2001, Journal of leukocyte biology.

[24]  C. Frank,et al.  Efficient transfer of intact oligonucleotides into the nucleus of ligament scar fibroblasts by HVJ-cationic liposomes is correlated with effective antisense gene inhibition. , 2001, Journal of biochemistry.

[25]  Y. Kaneda,et al.  Safety evaluation of hemagglutinating virus of Japan--artificial viral envelope liposomes in nonhuman primates. , 2001, Human gene therapy.

[26]  J. Drijfhout,et al.  Identification of Major Epitopes of Mycobacterium tuberculosis AG85B That Are Recognized by HLA-A*0201-Restricted CD8+ T Cells in HLA-Transgenic Mice and Humans1 , 2000, The Journal of Immunology.

[27]  Mary S. Wu,et al.  Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine. , 2000, Vaccine.

[28]  Alan D. Roberts,et al.  Lack of Protection in Mice and Necrotizing Bronchointerstitial Pneumonia with Bronchiolitis in Guinea Pigs Immunized with Vaccines Directed against the hsp60 Molecule ofMycobacterium tuberculosis , 2000, Infection and Immunity.

[29]  E. Kobayashi,et al.  Direct immunization of malaria DNA vaccine into the liver by gene gun protects against lethal challenge of Plasmodium berghei sporozoite. , 2000, Biochemical and biophysical research communications.

[30]  J. Maguire,et al.  Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers. , 2000, Vaccine.

[31]  K. Moelling,et al.  Therapy of tuberculosis in mice by DNA vaccination , 1999, Nature.

[32]  C. L. Silva,et al.  The potential use of heat-shock proteins to vaccinate against mycobacterial infections. , 1999, Microbes and infection.

[33]  K. Huygen.  DNA vaccines: application to tuberculosis. , 1998, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[34]  Alan D. Roberts,et al.  Evaluation of New Vaccines in the Mouse and Guinea Pig Model of Tuberculosis , 1998, Infection and Immunity.

[35]  H. Dockrell,et al.  Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[36]  C. L. Silva,et al.  DNA vaccines against tuberculosis , 1997, Current opinion in molecular therapeutics.

[37]  Y. Kaneda,et al.  Development and characterization of cationic liposomes conjugated with HVJ (Sendai virus): reciprocal effect of cationic lipid for in vitro and in vivo gene transfer. , 1997, Human gene therapy.

[38]  I. Orme,et al.  Interleukin 12 (IL-12) Is Crucial to the Development of Protective Immunity in Mice Intravenously Infected with Mycobacterium tuberculosis , 1997, The Journal of experimental medicine.

[39]  T Nomura,et al.  The anti-human tumor effect and generation of human cytotoxic T cells in SCID mice given human peripheral blood lymphocytes by the in vivo transfer of the Interleukin-6 gene using adenovirus vector. , 1997, Cancer research.

[40]  M. Colston,et al.  Vaccination against tuberculosis by DNA injection , 1996, Nature Medicine.

[41]  L. Lee,et al.  The glycoprotein B genes of Marek's disease virus serotypes 2 and 3: identification and expression by recombinant fowlpox viruses. , 1994, Virology.

[42]  T. Hirano,et al.  IL-6/BSF-2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells. , 1988, Journal of immunology.

[43]  N. Yoshida,et al.  B cell growth factors and B cell differentiation factor from human T hybridomas. Two distinct kinds of B cell growth factor and their synergism in B cell proliferation , 1983, The Journal of experimental medicine.

[44]  T. Kishimoto,et al.  Establishment and characterization of human T hybrid cells secreting immunoregulatory molecules. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[45]  C. Henney,et al.  The differentiation of cytotoxic T cells in vitro. I. Amplifying factor(s) in the primary response is Lyt 1 + cell dependent. , 1979, Journal of immunology.

[46]  T. Kishimoto,et al.  LPS-or 8Br-cyclic AMP-induced production of T cell-activating factor(s) in macrophage tumor cell line J774.1. , 1978, Journal of immunology.

[47]  S. Kaufmann,et al.  Exploiting the immune system: toward new vaccines against intracellular bacteria. , 2000, Advances in immunology.

[48]  D. Weiner,et al.  Enhancement of cellular immune response in HIV-1 seropositive individuals: A DNA-based trial. , 1999, Clinical immunology.

[49]  R. Mulligan,et al.  Bioactive murine and human interleukin-12 fusion proteins which retain antitumor activity in vivo , 1997, Nature Biotechnology.

[50]  Lajos Pusztai,et al.  Cell proliferation in cancer : regulatory mechanisms of neoplastic cell growth , 1996 .

[51]  D. McMurray,et al.  Guinea Pig Model of Tuberculosis , 1994 .

[52]  B. Bloom,et al.  Tuberculosis Pathogenesis, Protection, and Control , 1994 .